APO RESEARCH · REPORT
3-in-1 Oral CBCT
3-in-1 Oral CBCT is a medical imaging or procedural device supplied for the named examination or intervention.
Product & engineering
Understand the product.
The imaging or procedural modality, patient interface, connected instruments and product-specific validation define its use. Device appearance or a dimensional label does not establish an indication or clinical outcome.
The commercial boundary
The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.
Which modality and connected clinical interfaces define the device?
The imaging or procedural modality, patient interface, connected instruments and product-specific validation define its use. Device appearance or a dimensional label does not establish an indication or clinical outcome.
Selected research
Industry Research
3-in-1 Oral CBCT Industry Research Report 2026
Market perspective
The global 3-in-1 Oral CBCT market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 3-in-1 Oral CBCT is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 3-in-1 Oral CBCT is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 3-in-1 Oral CBCT is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 3-in-1 Oral CBCT include Instrumentarium, Vatech, Carestream Health, Planmeca, Hefei Meyer, Ray Co., Ltd, Guangzhou Huaduantech, FUSSEN and Shanghai Bondent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 3-in-1 Oral CBCT market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
3-in-1 Oral CBCT Market by Company
Instrumentarium
Vatech
Carestream Health
Planmeca
Hefei Meyer
Ray Co., Ltd
Guangzhou Huaduantech
FUSSEN
Shanghai Bondent
Beijing Largev
Shenzhen Angell
Pointnix
NewTom
KaVo Dental
Genoray
DEXIS
3-in-1 Oral CBCT Segment by Type
Big FOV
Medium and Small FOV
3-in-1 Oral CBCT Segment by Application
Private Clinic
Hospital
3-in-1 Oral CBCT Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3-in-1 Oral CBCT market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 3-in-1 Oral CBCT and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3-in-1 Oral CBCT.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 3-in-1 Oral CBCT manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 3-in-1 Oral CBCT by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 3-in-1 Oral CBCT in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Big FOV
- Medium and Small FOV
Applications
- Private Clinic
- Hospital
Companies covered
- Instrumentarium
- Vatech
- Carestream Health
- Planmeca
- Hefei Meyer
- Ray Co., Ltd
- Guangzhou Huaduantech
- FUSSEN
- Shanghai Bondent
- Beijing Largev
- Shenzhen Angell
- Pointnix
- NewTom
- KaVo Dental
- Genoray
- DEXIS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global 3-in-1 Oral CBCT Market Size (2021-2032)
- 2.2.2 Global 3-in-1 Oral CBCT Sales (2021-2032)
- 2.2.3 Global 3-in-1 Oral CBCT Market Average Price (2021-2032)
- 2.3 3-in-1 Oral CBCT by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Big FOV
- 2.3.3 Medium and Small FOV
- 2.4 3-in-1 Oral CBCT by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Private Clinic
- 2.4.3 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 3-in-1 Oral CBCT Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global 3-in-1 Oral CBCT Sales (units) of Manufacturers (2021-2026)
- 3.3 Global 3-in-1 Oral CBCT Revenue of Manufacturers (2021-2026)
- 3.4 Global 3-in-1 Oral CBCT Average Price by Manufacturers (2021-2026)
- 3.5 Global 3-in-1 Oral CBCT Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of 3-in-1 Oral CBCT, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of 3-in-1 Oral CBCT, Product Type & Application
- 3.8 Global Manufacturers of 3-in-1 Oral CBCT, Established Date
- 3.9 Global 3-in-1 Oral CBCT Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Instrumentarium
- 4.1.1 Instrumentarium Company Information
- 4.1.2 Instrumentarium Business Overview
- 4.1.3 Instrumentarium 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Instrumentarium 3-in-1 Oral CBCT Product Portfolio
- 4.1.5 Instrumentarium Recent Developments
- 4.2 Vatech
- 4.2.1 Vatech Company Information
- 4.2.2 Vatech Business Overview
- 4.2.3 Vatech 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Vatech 3-in-1 Oral CBCT Product Portfolio
- 4.2.5 Vatech Recent Developments
- 4.3 Carestream Health
- 4.3.1 Carestream Health Company Information
- 4.3.2 Carestream Health Business Overview
- 4.3.3 Carestream Health 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Carestream Health 3-in-1 Oral CBCT Product Portfolio
- 4.3.5 Carestream Health Recent Developments
- 4.4 Planmeca
- 4.4.1 Planmeca Company Information
- 4.4.2 Planmeca Business Overview
- 4.4.3 Planmeca 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Planmeca 3-in-1 Oral CBCT Product Portfolio
- 4.4.5 Planmeca Recent Developments
- 4.5 Hefei Meyer
- 4.5.1 Hefei Meyer Company Information
- 4.5.2 Hefei Meyer Business Overview
- 4.5.3 Hefei Meyer 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hefei Meyer 3-in-1 Oral CBCT Product Portfolio
- 4.5.5 Hefei Meyer Recent Developments
- 4.6 Ray Co., Ltd
- 4.6.1 Ray Co., Ltd Company Information
- 4.6.2 Ray Co., Ltd Business Overview
- 4.6.3 Ray Co., Ltd 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ray Co., Ltd 3-in-1 Oral CBCT Product Portfolio
- 4.6.5 Ray Co., Ltd Recent Developments
- 4.7 Guangzhou Huaduantech
- 4.7.1 Guangzhou Huaduantech Company Information
- 4.7.2 Guangzhou Huaduantech Business Overview
- 4.7.3 Guangzhou Huaduantech 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangzhou Huaduantech 3-in-1 Oral CBCT Product Portfolio
- 4.7.5 Guangzhou Huaduantech Recent Developments
- 4.8 FUSSEN
- 4.8.1 FUSSEN Company Information
- 4.8.2 FUSSEN Business Overview
- 4.8.3 FUSSEN 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 FUSSEN 3-in-1 Oral CBCT Product Portfolio
- 4.8.5 FUSSEN Recent Developments
- 4.9 Shanghai Bondent
- 4.9.1 Shanghai Bondent Company Information
- 4.9.2 Shanghai Bondent Business Overview
- 4.9.3 Shanghai Bondent 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai Bondent 3-in-1 Oral CBCT Product Portfolio
- 4.9.5 Shanghai Bondent Recent Developments
- 4.10 Beijing Largev
- 4.10.1 Beijing Largev Company Information
- 4.10.2 Beijing Largev Business Overview
- 4.10.3 Beijing Largev 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Beijing Largev 3-in-1 Oral CBCT Product Portfolio
- 4.10.5 Beijing Largev Recent Developments
- 4.11 Shenzhen Angell
- 4.11.1 Shenzhen Angell Company Information
- 4.11.2 Shenzhen Angell Business Overview
- 4.11.3 Shenzhen Angell 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shenzhen Angell 3-in-1 Oral CBCT Product Portfolio
- 4.11.5 Shenzhen Angell Recent Developments
- 4.12 Pointnix
- 4.12.1 Pointnix Company Information
- 4.12.2 Pointnix Business Overview
- 4.12.3 Pointnix 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Pointnix 3-in-1 Oral CBCT Product Portfolio
- 4.12.5 Pointnix Recent Developments
- 4.13 NewTom
- 4.13.1 NewTom Company Information
- 4.13.2 NewTom Business Overview
- 4.13.3 NewTom 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 NewTom 3-in-1 Oral CBCT Product Portfolio
- 4.13.5 NewTom Recent Developments
- 4.14 KaVo Dental
- 4.14.1 KaVo Dental Company Information
- 4.14.2 KaVo Dental Business Overview
- 4.14.3 KaVo Dental 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 KaVo Dental 3-in-1 Oral CBCT Product Portfolio
- 4.14.5 KaVo Dental Recent Developments
- 4.15 Genoray
- 4.15.1 Genoray Company Information
- 4.15.2 Genoray Business Overview
- 4.15.3 Genoray 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Genoray 3-in-1 Oral CBCT Product Portfolio
- 4.15.5 Genoray Recent Developments
- 4.16 DEXIS
- 4.16.1 DEXIS Company Information
- 4.16.2 DEXIS Business Overview
- 4.16.3 DEXIS 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 DEXIS 3-in-1 Oral CBCT Product Portfolio
- 4.16.5 DEXIS Recent Developments
5 Global 3-in-1 Oral CBCT Market Scenario by Region
- 5.1 Global 3-in-1 Oral CBCT Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global 3-in-1 Oral CBCT Sales by Region: 2021-2032
- 5.2.1 Global 3-in-1 Oral CBCT Sales by Region: 2021-2026
- 5.2.2 Global 3-in-1 Oral CBCT Sales by Region: 2027-2032
- 5.3 Global 3-in-1 Oral CBCT Revenue by Region: 2021-2032
- 5.3.1 Global 3-in-1 Oral CBCT Revenue by Region: 2021-2026
- 5.3.2 Global 3-in-1 Oral CBCT Revenue by Region: 2027-2032
- 5.4 North America 3-in-1 Oral CBCT Market Facts & Figures by Country
- 5.4.1 North America 3-in-1 Oral CBCT Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America 3-in-1 Oral CBCT Sales by Country (2021-2032)
- 5.4.3 North America 3-in-1 Oral CBCT Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe 3-in-1 Oral CBCT Market Facts & Figures by Country
- 5.5.1 Europe 3-in-1 Oral CBCT Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe 3-in-1 Oral CBCT Sales by Country (2021-2032)
- 5.5.3 Europe 3-in-1 Oral CBCT Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific 3-in-1 Oral CBCT Market Facts & Figures by Country
- 5.6.1 Asia Pacific 3-in-1 Oral CBCT Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific 3-in-1 Oral CBCT Sales by Country (2021-2032)
- 5.6.3 Asia Pacific 3-in-1 Oral CBCT Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America 3-in-1 Oral CBCT Market Facts & Figures by Country
- 5.7.1 South America 3-in-1 Oral CBCT Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America 3-in-1 Oral CBCT Sales by Country (2021-2032)
- 5.7.3 South America 3-in-1 Oral CBCT Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa 3-in-1 Oral CBCT Market Facts & Figures by Country
- 5.8.1 Middle East and Africa 3-in-1 Oral CBCT Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa 3-in-1 Oral CBCT Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa 3-in-1 Oral CBCT Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global 3-in-1 Oral CBCT Sales by Type (2021-2032)
- 6.1.1 Global 3-in-1 Oral CBCT Sales by Type (2021-2032) & (units)
- 6.1.2 Global 3-in-1 Oral CBCT Sales Market Share by Type (2021-2032)
- 6.2 Global 3-in-1 Oral CBCT Revenue by Type (2021-2032)
- 6.2.1 Global 3-in-1 Oral CBCT Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global 3-in-1 Oral CBCT Revenue Market Share by Type (2021-2032)
- 6.3 Global 3-in-1 Oral CBCT Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global 3-in-1 Oral CBCT Sales by Application (2021-2032)
- 7.1.1 Global 3-in-1 Oral CBCT Sales by Application (2021-2032) & (units)
- 7.1.2 Global 3-in-1 Oral CBCT Sales Market Share by Application (2021-2032)
- 7.2 Global 3-in-1 Oral CBCT Revenue by Application (2021-2032)
- 7.2.1 Global 3-in-1 Oral CBCT Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global 3-in-1 Oral CBCT Revenue Market Share by Application (2021-2032)
- 7.3 Global 3-in-1 Oral CBCT Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 3-in-1 Oral CBCT Value Chain Analysis
- 8.1.1 3-in-1 Oral CBCT Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 3-in-1 Oral CBCT Production Mode & Process
- 8.2 3-in-1 Oral CBCT Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 3-in-1 Oral CBCT Distributors
- 8.2.3 3-in-1 Oral CBCT Customers
9 Global 3-in-1 Oral CBCT Analyzing Market Dynamics
- 9.1 3-in-1 Oral CBCT Industry Trends
- 9.2 3-in-1 Oral CBCT Industry Drivers
- 9.3 3-in-1 Oral CBCT Industry Opportunities and Challenges
- 9.4 3-in-1 Oral CBCT Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst